New York State Common Retirement Fund Has $4.34 Million Holdings in Teleflex Incorporated (NYSE:TFX)

New York State Common Retirement Fund reduced its position in Teleflex Incorporated (NYSE:TFX) by 5.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,400 shares of the medical technology company’s stock after selling 1,500 shares during the period. New York State Common Retirement Fund owned about 0.05% of Teleflex worth $4,343,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Avior Wealth Management LLC increased its position in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 101 shares during the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of Teleflex during the 3rd quarter worth about $40,000. True Wealth Design LLC boosted its stake in shares of Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after acquiring an additional 166 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in shares of Teleflex during the 3rd quarter worth about $54,000. Finally, Banque Cantonale Vaudoise boosted its stake in shares of Teleflex by 184.8% during the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock worth $56,000 after acquiring an additional 146 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of TFX stock opened at $132.58 on Friday. The stock has a 50 day moving average of $175.44 and a two-hundred day moving average of $205.04. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $130.60 and a 12 month high of $249.90. The company has a market capitalization of $6.16 billion, a P/E ratio of 26.36, a P/E/G ratio of 1.73 and a beta of 1.16.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be given a $0.34 dividend. The ex-dividend date is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.03%. Teleflex’s dividend payout ratio is currently 27.04%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Truist Financial decreased their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Mizuho decreased their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday. Finally, Royal Bank of Canada downgraded Teleflex from an “outperform” rating to a “sector perform” rating and decreased their target price for the company from $220.00 to $155.00 in a research note on Friday. Nine research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $196.83.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.